< Back to situations

Monitor this situation.

[SITUATION] · [ACTIVE] · [HEALTH]

3 clusters · 21 sources · 15 days · First seen · Last updated

Medical diagnosis delays in Brazil

Overview

Medical professionals and researchers in Brazil are reporting significant delays in the diagnosis of various conditions, which negatively impact patient outcomes.

In oncology, data from the National Cancer Institute (INCA) indicates that late detection reduces survival rates. For lung cancer, only 16% of cases are identified in early stages, and for head and neck cancers, over 80% of patients reach treatment in advanced stages. Similarly, colon cancer survival rates drop from 91% for localized cases to 13% once the disease has spread.

Neurological and neurodevelopmental conditions also face diagnostic challenges. Research from the Brazilian Multiple Sclerosis Association (ABEM) shows that 25% of multiple sclerosis patients wait more than five years for a diagnosis, with many receiving incorrect initial assessments. In the case of autism, studies indicate delays of up to 49 months between the observation of symptoms and formal diagnosis due to specialist waiting lists and missed investigative opportunities.

Furthermore, patients with rare diseases face an average five-year gap between symptom onset and definitive diagnosis. Experts suggest that improving access to high-complexity exams and transforming patient data into clinical intelligence may be necessary to bridge these gaps.

Entities

American Cancer Society · Roche Farma · Rodrigo Kleinpaul · Einstein Hospital Israelita · Rede Brasileira de Doenças Raras

Timeline

  1. 2 days ago

    [HEALTH] 2 sources
    Brazil faces significant delays in rare disease and autism diagnoses

    Research in Brazil reveals significant diagnostic delays, with rare disease patients waiting an average of five years and autism diagnoses taking up to 49 months from initial symptom recognition.

  2. 16 days ago

    [HEALTH] 17 sources
    Multiple sclerosis diagnosis delays increase disability risk in Brazil

    A study by ABEM reveals that many Brazilian multiple sclerosis patients face significant diagnostic delays, often waiting over five years, which increases the risk of permanent neurological damage.

  3. 17 days ago

    [HEALTH] 2 sources
    Cancer diagnosis delays impact survival rates in Brazil

    Medical experts warn that late diagnosis in Brazil significantly hinders cancer treatment, with lung cancer and head and neck cancers frequently identified only in advanced stages.

Sources

actu.capital.fr · aquiacontece.com.br · caririceara.com · cbnsantos.com.br · correiodecarajas.com.br · destakjornal.com.br · diariodecanoas.com.br · ejornais.com.br · fatopaulista.com.br · itapevinoticias.jor.br · jeremoaboagora.com.br · leianoticias.com.br · maranhaodagente.com.br · portalolm.com.br · reporterbrasilia.com.br · revistaforum.com.br · revistagalileu.globo.com · revistaviverbrasil.com.br · saude.ig.com.br · tconline.com.br · tribunadaserra.com.br